Delfi Diagnostics Begins Enrollment for Prospective Lung Cancer Screening Trial ahead of Planned Commercial Test
Spoke,
Receives Breakthrough Device Designation from the Food and Drug Administration Announces Partnership with NYU Langone to…
Receives Breakthrough Device Designation from the Food and Drug Administration Announces Partnership with NYU Langone to…
Receives Breakthrough Device Designation from the Food and Drug AdministrationAnnounces Partnership with NYU Langone to…
BALTIMORE, March 31, 2021 /PRNewswire/ --, Inc., a pioneering developer of next generation high performance, affordable liquid…
BALTIMORE, March 31, 2021 /PRNewswire/ --, Inc., a pioneering developer of next generation high performance, affordable liquid…
BALTIMORE, March 31, 2021 /PRNewswire/ --, Inc., a pioneering developer of next generation high performance, affordable liquid…
Receives Breakthrough Device Designation from the Food and Drug Administration Announces Partnership with NYU Langone to…
BALTIMORE, March 31, 2021 / / -- Delfi Diagnostics, Inc., a pioneering developer of next generation high performance…
BALTIMORE, March 31, 2021 /PRNewswire/ -- Delfi Diagnostics, Inc., a pioneering developer of next generation high performance…